1
Edwin D Kilbourne: Influenza vaccine containing a recombinant, antigenically hybridized virus and method of using the same. The Mount Sinai School of Medicine of the City University of New York, Brumbaugh Graves Donohue & Raymond, February 22, 1977: US04009258 (24 worldwide citation)

An influenza vaccine is disclosed which comprises, as an active ingredient, a recombinant, antigenically hydridized virus which has a hemagglutinin antigen that has substantially no cross-reactivity with those influenza viruses against which the vaccine is to be effective and a neuraminidase antigen ...


2
Edwin D Kilbourne: Influenza vaccine containing purified neuraminidase antigen and method of using the same. Mount Sinai School of Medicine of the City University of New York, Brumbaugh Graves Donohue & Raymond, June 14, 1977: US04029763 (17 worldwide citation)

An influenza vaccine is disclosed which comprises, as an active ingredient, neuraminidase antigen which has been isolated from an antigenically functional virus and has substantial cross-reactivity with the influenza virus against which the vaccine is to be effective. The neuraminidase antigen can b ...


3
Gail Eugene Smith, James T Matthews, Edwin D Kilbourne, Bert E Johansson, Bethanie E Wilkinson, Andrei I Voznesensky, Craig S Hackett, Franklin Volvovitz: Neuraminidase-supplemented compositions. Protein Sciences Corporation, William S Frommer, Thomas J Kowalski, Frommer Lawrence & Haug, November 26, 2002: US06485729 (11 worldwide citation)

An anti-influenza vaccine composition wherein the improvement is that the vaccine includes, as an additive, neuraminidase (NA). The base anti-influenza vaccine can be any commercially available anti-influenza vaccine. The composition can include and be administered with an adjuvant. The vaccine comp ...


4
Gail Eugene Smith, James T Matthews, Edwin D Kilbourne, Bert E Johansson, Bethanie E Wilkinson, Andrie I Voznesensky, Craig S Hackett, Franklin Volvovitz: Methods of making neuraminidase-supplemented compositions. Protein Sciences Corporation, Frommer Lawrence & Haug, Thomas J Kowalski, Angela M Collison, October 4, 2005: US06951649 (4 worldwide citation)

The present invention relates to a method for formulating a vaccine composition which comprises an anti-influenza vaccine, wherein the improvement of the vaccine composition is that the vaccine includes, as an additive, neuraminidase (NA). The base anti-influenza vaccine can be any commercially avai ...


5

6
Gale Eugene Smith, James T Matthews, Edwin D Kilbourne, Bert E Johansson, Bethanie E Wilkinson, Andrei I Voznesensky, Craig S Hackett, Franklin Volvovitz: Neuraminidase-supplemented compositions. Frommer Lawrence & Haug, September 4, 2003: US20030165521-A1

An anti-influenza vaccine composition wherein the improvement is that the vaccine includes, as an additive, neuraminidase (NA). The base anti-influenza vaccine can be any commercially available anti-influenza vaccine. The composition can include and be administered with an adjuvant. The vaccine comp ...


7


Click the thumbnails below to visualize the patent trend.